Mobile

A study to assess patient preference after subcutaneous injections of Mabthera versus intravenous infusions Mabthera in previously-untreated patients with diffuse large B-cell lymphoma or follicular...

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-003230-17

A study to assess patient preference after subcutaneous injections of Mabthera versus intravenous infusions Mabthera in previously-untreated patients with diffuse large B-cell lymphoma or follicular non-Hodgkin’s lymphoma

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

•To evaluate the proportion of patients indicating an overall preference via a Patient Preference Questionnaire (PPQ) for either the SC or the IV route of rituximab administration.

Critère d'inclusion

  • The target population will consist of adults with previously untreated CD20+ DLBCL or CD20+ follicular NHL Grade 1, 2 or 3a, according to the WHO classification system

Liens